BGC vs SRPT · P/E 40, rev $2.26B vs rev $1.90B
BGC Group Inc. (BGC) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
BGC Group Inc. (BGC) is a capital markets company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported BGC revenue for 2024-12-31 was $2.26B. Net income was $123.2M. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. BGC currently screens at market cap $5.09B and trailing P/E 40.1.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
BGC currently screens at market cap $5.09B and trailing P/E 40.1. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the BGC and SRPT stock pages for the full models.
Not investment advice.